A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)
Clinical trial NCT00489099 · COMPLETED
Trial details
- NCT number
- NCT00489099
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2006-05-01
- Enrollment
- 860
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.